Bayer to buy BIVI's Cydectin parasiticidesDecember 13, 2016Bayer Animal Health of Shawnee, Kan., will acquire BIVI’s Cydectin (moxidectin) line, which is formulated to control parasites in cattle and sheep, the companies announced Dec. 7.
Education Center - SponsoredHow artificial intelligence can enhance diagnostic confidenceby • ZoetisIn the right context, AI yields the power to enhance clinical confidence and streamline decision-making – without replacing the human touch that defines the profession.
New feline core vaccine available from BIVIAugust 18, 2016Boehringer Ingelheim Vetmedica Inc. has released a reduced-volume core vaccine for cats. The nonadjuvanted Ultra Hybrid FVRCP is administered in a 0.5 mL subcutaneous dose to protect against feline herpesvirus, calicivirus infection and distemper in cats at least 8 weeks old.
